The U.S. Supreme Court upheld the availability of abortion drug mifepristone without new restrictions, rejecting claims that the FDA acted improperly. The legal battle is not over, as Republican-led states like Idaho, Missouri, and Kansas may continue to seek restrictions. This ongoing conflict could result in prolonged legal uncertainty.